Cyclerion Therapeutics (CYCN) Receivables - Net (2021 - 2025)
Cyclerion Therapeutics has reported Receivables - Net over the past 5 years, most recently at $100000.0 for Q3 2025.
- Quarterly results put Receivables - Net at $100000.0 for Q3 2025, up 127.27% from a year ago — trailing twelve months through Sep 2025 was $100000.0 (up 127.27% YoY), and the annual figure for FY2024 was $556000.0, changed.
- Receivables - Net for Q3 2025 was $100000.0 at Cyclerion Therapeutics, down from $525000.0 in the prior quarter.
- Over the last five years, Receivables - Net for CYCN hit a ceiling of $581000.0 in Q1 2025 and a floor of $44000.0 in Q3 2024.
- Median Receivables - Net over the past 5 years was $192500.0 (2021), compared with a mean of $244750.0.
- Biggest five-year swings in Receivables - Net: plummeted 57.71% in 2023 and later skyrocketed 127.27% in 2025.
- Cyclerion Therapeutics' Receivables - Net stood at $100000.0 in 2021, then decreased by 4.0% to $96000.0 in 2022, then changed by 0.0% to $96000.0 in 2023, then skyrocketed by 479.17% to $556000.0 in 2024, then tumbled by 82.01% to $100000.0 in 2025.
- The last three reported values for Receivables - Net were $100000.0 (Q3 2025), $525000.0 (Q2 2025), and $581000.0 (Q1 2025) per Business Quant data.